Acadian Asset Management LLC Has $118,000 Holdings in Sotera Health (NASDAQ:SHC)

Acadian Asset Management LLC lifted its holdings in shares of Sotera Health (NASDAQ:SHC) by 268.2% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 6,286 shares of the company’s stock after purchasing an additional 4,579 shares during the period. Acadian Asset Management LLC’s holdings in Sotera Health were worth $118,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Mitsubishi UFJ Trust & Banking Corp acquired a new position in Sotera Health in the first quarter valued at $28,000. Signaturefd LLC increased its stake in Sotera Health by 50.5% in the second quarter. Signaturefd LLC now owns 1,804 shares of the company’s stock valued at $34,000 after purchasing an additional 605 shares in the last quarter. BNP Paribas Arbitrage SNC bought a new stake in Sotera Health in the third quarter valued at $37,000. Jefferies Financial Group Inc. bought a new stake in Sotera Health in the fourth quarter valued at $43,000. Finally, Wells Fargo & Company MN increased its stake in Sotera Health by 30.7% in the fourth quarter. Wells Fargo & Company MN now owns 6,455 shares of the company’s stock valued at $54,000 after purchasing an additional 1,518 shares in the last quarter. Institutional investors and hedge funds own 88.89% of the company’s stock.

Sotera Health Trading Up 2.0 %

NASDAQ:SHC opened at $13.93 on Tuesday. The company has a debt-to-equity ratio of 6.06, a current ratio of 2.59 and a quick ratio of 2.40. The firm has a 50-day moving average of $13.97 and a 200-day moving average of $15.59. The company has a market cap of $3.94 billion, a PE ratio of -12.66 and a beta of 2.26. Sotera Health has a one year low of $7.65 and a one year high of $19.40.

Analysts Set New Price Targets

SHC has been the subject of several research analyst reports. KeyCorp decreased their price target on shares of Sotera Health from $24.00 to $23.00 and set an “overweight” rating for the company in a research note on Friday, August 4th. Barclays decreased their price target on shares of Sotera Health from $20.00 to $15.00 and set an “overweight” rating for the company in a research note on Thursday, November 2nd. Finally, Royal Bank of Canada decreased their price target on shares of Sotera Health from $22.00 to $20.00 and set an “outperform” rating for the company in a research note on Thursday, November 2nd. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $18.17.

Sotera Health Company Profile

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing. It also provides microbiological and analytical chemistry testing, and advisory services.